TuisTEVA ā¢ TLV
add
Teva Pharmaceutical Industries Ltd
Vorige sluiting
ILAĀ 5Ā 695,00
Dagwisseling
ILAĀ 5Ā 801,00 - ILAĀ 6Ā 048,00
Jaarwisseling
ILAĀ 4Ā 807,00 - ILAĀ 8Ā 431,00
Markkapitalisasie
18,71Ā mjd USD
Gemiddelde volume
1,64Ā m
P/V-verhouding
-
Dividend-opbrengs
-
PrimĆŖre beurs
TLV
In die nuus
BARC
3,53%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Des. 2024info | J/J-verandering |
---|---|---|
Inkomste | 4,23Ā mjd | -5,12% |
Bedryfskoste | 1,23Ā mjd | 5,32% |
Netto inkomste | -217,00Ā m | -146,87% |
Netto winsgrens | -5,13 | -149,37% |
Wins per aandeel | 0,71 | -29,00% |
EBITDA | 1,16Ā mjd | -23,40% |
Effektiewe belastingkoers | -11,34% | ā |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Des. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 3,30Ā mjd | 2,29% |
Totale bates | 39,33Ā mjd | -9,55% |
Totale aanspreeklikheid | 33,61Ā mjd | -4,94% |
Totale ekwiteit | 5,72Ā mjd | ā |
Uitstaande aandele | 1,13Ā mjd | ā |
Prys om te bespreek | 12,01 | ā |
Opbrengs op bates | 5,51% | ā |
Opbrengs op kapitaal | 9,01% | ā |
Kontantvloei
Netto kontantverandering
(USD) | Des. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -217,00Ā m | -146,87% |
Kontant van bedrywe | 575,00Ā m | -51,44% |
Kontant van beleggings | 202,00Ā m | -32,89% |
Kontant van finansiering | -674,00Ā m | -17,01% |
Netto kontantverandering | -19,00Ā m | -101,94% |
Beskikbare kontantvloei | -13,25Ā m | -101,08% |
Meer oor
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
Gestig
13 Feb. 1944
Webwerf
Werknemers
34Ā 789